Druggability for COVID-19: in silico discovery of potential drug compounds against nucleocapsid (N) protein of SARS-CoV-2. | Genomics Inform;18(4): e43, 2020 Dec. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Druggability for COVID-19: in silico discovery of potential drug compounds against nucleocapsid (N) protein of SARS-CoV-2.

Ray, Manisha; Sarkar, Saurav; Rath, Surya Narayan.

Affiliation

Ray M; All India Institute of Medical Sciences, Bhubaneswar, Odisha 751019, India.
Sarkar S; All India Institute of Medical Sciences, Bhubaneswar, Odisha 751019, India.
Rath SN; Department of Bioinformatics, Odisha University of Agriculture and Technology, Bhubaneswar, Odisha 751003, India.

Genomics Inform ; 18(4): e43, 2020 Dec.

Article in En | MEDLINE | ID: mdl-33412759

Key words

COVID-19; SARS-CoV-2; molecular docking; molecular modeling; nucleocapsid protein

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Genomics Inform Year: 2020 Document type: Article Affiliation country: India

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Genomics Inform Year: 2020 Document type: Article Affiliation country: India